OBJECTIVE: To evaluate the long-term effects of deep brain stimulation (DBS) on quality of life (QOL) in therapy-refractory obsessive-compulsive disorder (OCD) patients. DESIGN: 16 patients who met Diagnostic and Statistical Manual of Mental Disorders (4th ed) (DSM-IV) criteria for OCD and were considered therapy-refractory were treated with DBS. Patients were assessed 1 month before device implantation (T0), at 8 months of active stimulation (T1) and at 3-5 years of active stimulation (T2). QOL was measured with the WHO Quality of Life Scale-Brief Version (WHOQOL-BREF) that covers physical, psychological, social and environmental domains. The study was conducted between April 2005 and January 2011 at the Academic Medical Center, Amsterdam, The Netherlands. RESULTS: At T1 and T2, we found significant improvement (p<0.05) in the general score and in the physical, psychological and environmental domains of WHOQOL-BREF. Between T1 and T2, the physical and psychological domains improved further (p<0.05). At T2, the general score improved by a total of 90%, the physical and psychological domains both improved by 39.5% and the environmental domain improved by 16%. The social domain did not change between baseline and follow-up assessments. CONCLUSIONS: In line with symptom improvement, patient's QOL improved in the general score and in three of the four WHOQOL-BREF domains. This suggests that the improvement caused by DBS is not limited to symptom reduction alone, but also has a positive influence on patients' perception of their physical, psychological, environmental and global QOL. CLINICAL TRIAL REGISTRATION: http://isrctn.org identifier: ISRCTN23255677.
OBJECTIVE: To evaluate the long-term effects of deep brain stimulation (DBS) on quality of life (QOL) in therapy-refractory obsessive-compulsive disorder (OCD) patients. DESIGN: 16 patients who met Diagnostic and Statistical Manual of Mental Disorders (4th ed) (DSM-IV) criteria for OCD and were considered therapy-refractory were treated with DBS. Patients were assessed 1 month before device implantation (T0), at 8 months of active stimulation (T1) and at 3-5 years of active stimulation (T2). QOL was measured with the WHO Quality of Life Scale-Brief Version (WHOQOL-BREF) that covers physical, psychological, social and environmental domains. The study was conducted between April 2005 and January 2011 at the Academic Medical Center, Amsterdam, The Netherlands. RESULTS: At T1 and T2, we found significant improvement (p<0.05) in the general score and in the physical, psychological and environmental domains of WHOQOL-BREF. Between T1 and T2, the physical and psychological domains improved further (p<0.05). At T2, the general score improved by a total of 90%, the physical and psychological domains both improved by 39.5% and the environmental domain improved by 16%. The social domain did not change between baseline and follow-up assessments. CONCLUSIONS: In line with symptom improvement, patient's QOL improved in the general score and in three of the four WHOQOL-BREF domains. This suggests that the improvement caused by DBS is not limited to symptom reduction alone, but also has a positive influence on patients' perception of their physical, psychological, environmental and global QOL. CLINICAL TRIAL REGISTRATION: http://isrctn.org identifier: ISRCTN23255677.
Entities:
Keywords:
Neurosurgery; Psychiatry; Quality Of Life
Authors: Isidoor O Bergfeld; Eva Dijkstra; Ilse Graat; Pelle de Koning; Bastijn J G van den Boom; Tara Arbab; Nienke Vulink; Damiaan Denys; Ingo Willuhn; Roel J T Mocking Journal: Curr Top Behav Neurosci Date: 2021
Authors: Nicole R Provenza; Sameer A Sheth; Evan M Dastin-van Rijn; Raissa K Mathura; Yaohan Ding; Gregory S Vogt; Michelle Avendano-Ortega; Nithya Ramakrishnan; Noam Peled; Luiz Fernando Fracassi Gelin; David Xing; Laszlo A Jeni; Itir Onal Ertugrul; Adriel Barrios-Anderson; Evan Matteson; Andrew D Wiese; Junqian Xu; Ashwin Viswanathan; Matthew T Harrison; Kelly R Bijanki; Eric A Storch; Jeffrey F Cohn; Wayne K Goodman; David A Borton Journal: Nat Med Date: 2021-12-09 Impact factor: 87.241
Authors: Jimmy C Yang; George Papadimitriou; Ryan Eckbo; Edward H Yeterian; Lichen Liang; Darin D Dougherty; Sylvain Bouix; Yogesh Rathi; Martha Shenton; Marek Kubicki; Emad N Eskandar; Nikos Makris Journal: Brain Imaging Behav Date: 2015-06 Impact factor: 3.978
Authors: Pino Alonso; Daniel Cuadras; Loes Gabriëls; Damiaan Denys; Wayne Goodman; Ben D Greenberg; Fiacro Jimenez-Ponce; Jens Kuhn; Doris Lenartz; Luc Mallet; Bart Nuttin; Eva Real; Cinto Segalas; Rick Schuurman; Sophie Tezenas du Montcel; Jose M Menchon Journal: PLoS One Date: 2015-07-24 Impact factor: 3.240